|
Treatment of psoriasis with triacetoxianthracene (Exolan). A double-blind trial] - OG Rasmussen, H Zachariae.
|
|
In order to eliminate these adverse effects, certain derivatives have been prepared fromanthralin, e.g. 1,8,9-triacetoxy-anthracene (Exolan.RTM.). Exolan. ...
|
|
|
The triacetate is known as 1,8,9-anthracenetriol triacetate and, alternatively, as 1,8,9-triacetoxyanthracene, which is known commercially as Exolan. ...
|
|
Submit a response ... No responses publishe ... Search this site...
|
|
|
reinforced composites were purchased from Exolan-Esk Co. In both composite systems, the volume fraction of the reinforcements were about. 20 percent. ...
|
|
|
EOS OIL AND GAS PARTNERSHIP 1983 ... EOTT CANADA LTD. 1991 ... THE EXOLAN COMPANY OF CANADA LTD. 1981-1983...
|
|
|
A case of bilateral kerititis developing in a psoriatic patient using triacetoxy anthracene (Exolan) cream is presented. The symptoms and findings closely ...
|
|
|
an anti-psoriatic (Exolan) [5]). In vitro experiments using dithranol triacetate and dithranol diacetate with human serum have revealed that both molecules ...
|
|
|
and later topical Exolan (triacetoxyanthracene i'*,,), topical fluorinated corticosteroids, topical metho- trexate, oral chloroquin, oral erythromycin and ...
|
|
|
Topical Psoriasis Treatment information ... If tars are ineffective then use can be made of the proprietary preparations of dithranol (e.g. Dithrocream, Dithrolan, Exolan, Psora date and Stie-Lasan). At one time dithranol treatment was almost totally restricted to in-patients.
|